FDA Drug Approvals: Health Care Practitioners — Year in Review 2018

• New Antibiotics
  An aminoglycoside and three tetracyclines, with some designed to overcome resistance.

• New HIV Antiretrovirals
  New ARTs include a first-in-class postattachment inhibitor and fixed-dose combinations that provide complete drug regimens.

• Other New Antimicrobials
  New antimicrobials for influenza, malaria, onchocerciasis, smallpox, and more.

• New Drugs for Migraine
  New drug class approved for migraine prevention.

• New Pulmonary Drugs
  New approvals for COPD and cystic fibrosis.

• Other New Drugs
  New drugs for gynecology, cardiology/nephrology, gastroenterology, and more.

Medscape © 2019 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Mary L Windle. FDA Drug Approvals: Health Care Practitioners — Year in Review 2018 - Medscape - Jan 18, 2019.